Pharmacovigilance failures rarely announce themselves until it’s too late, a missed signal, a late PSUR, an inspection finding that could have been caught months earlier. If any of this sounds familiar, you are not alone:
- Your QPPV role has been vacant, understaffed, or stretched too thin across markets
- Adverse event case processing is falling behind, creating regulatory exposure
- You are unsure whether your PSMF would withstand an NMRA audit today
- Signal detection is reactive rather than proactive, leaving risks unmanaged for too long
- You need local PV representation in an African market, but have no presence there
Jeyflex exists to close exactly these gaps with hands-on, practitioner-led pharmacovigilance support across Kenya, Uganda, Tanzania, Rwanda, and Ethiopia.








